BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25661331)

  • 1. CRKL overexpression suppresses in vitro proliferation, invasion and migration of murine hepatocarcinoma Hca-P cells.
    Lin Q; Sun MZ; Guo C; Shi J; Chen X; Liu S
    Biomed Pharmacother; 2015 Feb; 69():11-7. PubMed ID: 25661331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRKL knockdown promotes in vitro proliferation, migration and invasion, in vivo tumor malignancy and lymph node metastasis of murine hepatocarcinoma Hca-P cells.
    Shi J; Meng L; Sun MZ; Guo C; Sun X; Lin Q; Liu S
    Biomed Pharmacother; 2015 Apr; 71():84-90. PubMed ID: 25960220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RACK1 promotes the proliferation, migration and invasion capacity of mouse hepatocellular carcinoma cell line in vitro probably by PI3K/Rac1 signaling pathway.
    Wu J; Meng J; Du Y; Huang Y; Jin Y; Zhang J; Wang B; Zhang Y; Sun M; Tang J
    Biomed Pharmacother; 2013 May; 67(4):313-9. PubMed ID: 23582786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRKII overexpression promotes the
    Zhou Z; Sun X; Guo C; Sun MZ; Liu S
    Oncol Lett; 2019 Jun; 17(6):5169-5174. PubMed ID: 31186732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANXA5 level is linked to in vitro and in vivo tumor malignancy and lymphatic metastasis of murine hepatocarcinoma cell.
    Peng B; Liu S; Guo C; Sun X; Sun MZ
    Future Oncol; 2016 Jan; 12(1):31-42. PubMed ID: 26615672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
    Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
    J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways.
    Sun X; Liu S; Wang J; Wei B; Guo C; Chen C; Sun MZ
    Cell Death Dis; 2018 May; 9(6):637. PubMed ID: 29802377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxa5 mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells with high lymph node metastasis potential preferentially via ERK2/p-ERK2/c-Jun/p-c-Jun(Ser73) and E-cadherin.
    Sun X; Wei B; Liu S; Guo C; Wu N; Liu Q; Sun MZ
    Biomed Pharmacother; 2016 Dec; 84():645-654. PubMed ID: 27697636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANXA11 regulates the tumorigenesis, lymph node metastasis and 5-fluorouracil sensitivity of murine hepatocarcinoma Hca-P cells by targeting c-Jun.
    Liu S; Guo C; Wang J; Wang B; Qi H; Sun MZ
    Oncotarget; 2016 Mar; 7(13):16297-310. PubMed ID: 26908448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Ech1 overexpression on biological behavior of mouse hepatocarcinoma Hca-P cells in vitro].
    Wang M; Song B; Wang B; Zhang J; Tang JW
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):337-40. PubMed ID: 24054008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms.
    Wang XY; Gao F; Sun YR; Bai LL; Ibrahim MM; Wang B; Tang JW
    Tumour Biol; 2016 Jan; 37(1):911-24. PubMed ID: 26256045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezrin expression is altered in mice lymphatic metastatic hepatocellular carcinoma and subcellular fractions upon Annexin 7 modulation in-vitro.
    Hago AM; Gamallat Y; Mahmoud SA; Huang Y; Zhang J; Mahmoud YK; Wang J; Wei Y; Wang L; Zhou S; Awsh MA; Yabasin IB; Tang J
    Biomed Pharmacother; 2017 Jan; 85():209-217. PubMed ID: 27914826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt.
    Guo C; Gao C; Lv X; Zhao D; Greenaway FT; Hao L; Tian Y; Liu S; Sun MZ
    J Cell Mol Med; 2021 Mar; 25(5):2714-2724. PubMed ID: 33523562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability.
    Zhou H; Jia L; Wang S; Wang H; Chu H; Hu Y; Cao J; Zhang J
    Biochem Biophys Res Commun; 2006 Jun; 345(1):486-94. PubMed ID: 16684506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Horizontal transfer of exosomal CXCR4 promotes murine hepatocarcinoma cell migration, invasion and lymphangiogenesis.
    Li M; Lu Y; Xu Y; Wang J; Zhang C; Du Y; Wang L; Li L; Wang B; Shen J; Tang J; Song B
    Gene; 2018 Nov; 676():101-109. PubMed ID: 30010038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FoxM1 influences mouse hepatocellular carcinoma metastasis in vitro.
    Zhang N; Xie Y; Li B; Ning Z; Wang A; Cui X
    Int J Clin Exp Pathol; 2015; 8(3):2771-8. PubMed ID: 26045783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialylated β1, 6 branched N-glycans modulate the adhesion, invasion and metastasis of hepatocarcinoma cells.
    Yu X; Zhao Y; Wang L; Chen X; Su Z; Zhang H; Yuan Q; Wang S
    Biomed Pharmacother; 2016 Dec; 84():1654-1661. PubMed ID: 27847205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A7 gene is an important factor in the lymphatic metastasis of tumors.
    Jin YL; Wang ZQ; Qu H; Wang HX; Ibrahim MM; Zhang J; Huang YH; Wu J; Bai LL; Wang XY; Meng JY; Tang JW
    Biomed Pharmacother; 2013 May; 67(4):251-9. PubMed ID: 23540285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.
    Wang J; Chen X; Li P; Su L; Yu B; Cai Q; Li J; Yu Y; Liu B; Zhu Z
    Chem Biol Interact; 2013 Nov; 206(2):230-8. PubMed ID: 24055140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of sulfatase-1 in murine hepatocarcinoma Hca-F cell line downregulates mesothelin and leads to reduction in lymphatic metastasis, both in vitro and in vivo.
    Mahmoud S; Ibrahim M; Hago A; Huang Y; Wei Y; Zhang J; Zhang Q; Xiao Y; Wang J; Adam M; Guo Y; Wang L; Zhou S; Xin B; Xuan W; Tang J
    Oncotarget; 2016 Nov; 7(46):75052-75063. PubMed ID: 27626699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.